Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 17 04:00PM ET
6.75
Dollar change
-0.14
Percentage change
-2.03
%
IndexRUT P/E- EPS (ttm)-0.57 Insider Own63.99% Shs Outstand306.56M Perf Week-1.46%
Market Cap2.08B Forward P/E9.96 EPS next Y0.68 Insider Trans-0.02% Shs Float111.14M Perf Month0.00%
Income-168.69M PEG- EPS next Q0.14 Inst Own27.23% Short Float3.25% Perf Quarter14.21%
Sales2.50B P/S0.83 EPS this Y-3.13% Inst Trans-0.43% Short Ratio2.28 Perf Half Y35.00%
Book/sh0.06 P/B104.62 EPS next Y9.35% ROA-4.76% Short Interest3.61M Perf Year150.00%
Cash/sh0.17 P/C40.36 EPS next 5Y3.00% ROE-146.19% 52W Range2.29 - 7.25 Perf YTD11.20%
Dividend Est.0.01 (0.22%) P/FCF- EPS past 5Y-23.74% ROI-6.88% 52W High-6.90% Beta1.24
Dividend TTM- Quick Ratio0.97 Sales past 5Y7.85% Gross Margin36.73% 52W Low194.76% ATR (14)0.24
Dividend Ex-Date- Current Ratio1.65 EPS Y/Y TTM36.92% Oper. Margin12.46% RSI (14)52.08 Volatility3.99% 3.44%
Employees7850 Debt/Eq- Sales Y/Y TTM9.82% Profit Margin-6.76% Recom2.00 Target Price8.25
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-553.95% Payout- Rel Volume0.75 Prev Close6.89
Sales Surprise6.49% EPS Surprise52.01% Sales Q/Q18.23% EarningsMay 03 BMO Avg Volume1.58M Price6.75
SMA20-0.17% SMA506.48% SMA20027.90% Trades Volume1,186,294 Change-2.03%
Date Action Analyst Rating Change Price Target Change
Apr-07-21Resumed RBC Capital Mkts Sector Perform $5
Mar-08-21Upgrade Goldman Sell → Buy $4 → $6.50
Dec-14-20Upgrade Guggenheim Neutral → Buy $5.50
Dec-14-20Upgrade Barclays Equal Weight → Overweight $4.50 → $6
Jul-27-20Initiated Goldman Sell $4
May-12-20Upgrade Guggenheim Sell → Neutral
Dec-12-19Downgrade Raymond James Outperform → Mkt Perform
Nov-12-19Downgrade JP Morgan Neutral → Underweight
Nov-07-19Downgrade SVB Leerink Outperform → Mkt Perform
Jul-22-19Upgrade SVB Leerink Mkt Perform → Outperform $11 → $5
Jun-05-24 08:00AM
May-23-24 07:03AM
May-22-24 04:05PM
04:05PM
May-20-24 07:01PM
06:15AM Loading…
May-16-24 06:15AM
May-04-24 03:05AM
May-03-24 03:35PM
10:53AM
09:30AM
07:10AM
06:00AM
Apr-25-24 05:48AM
Apr-24-24 08:00AM
Apr-16-24 08:00AM
08:00AM Loading…
Apr-10-24 08:00AM
Mar-28-24 04:05PM
Mar-25-24 04:05PM
Mar-20-24 06:11AM
Mar-04-24 09:07AM
Mar-01-24 09:30AM
07:15AM
06:32AM
06:00AM
Feb-27-24 08:00AM
Feb-13-24 08:00AM
Feb-08-24 04:05PM
Jan-31-24 04:05PM
Jan-25-24 07:30AM
Jan-10-24 08:00AM
04:05PM Loading…
Jan-04-24 04:05PM
Dec-22-23 10:54AM
Dec-21-23 08:00AM
Dec-15-23 04:05PM
Dec-07-23 08:00AM
Dec-01-23 08:00AM
Nov-08-23 05:57PM
Nov-07-23 09:30AM
07:04AM
06:22AM
06:00AM
Nov-03-23 12:40PM
08:00AM
Nov-01-23 10:01AM
07:15AM
Oct-31-23 10:01AM
09:55AM
Oct-25-23 12:00PM
09:40AM
Oct-23-23 04:05PM
Oct-17-23 12:10PM
Oct-12-23 08:00AM
Oct-06-23 08:50AM
Oct-05-23 08:00AM
Oct-04-23 09:40AM
Sep-06-23 04:00PM
08:01AM
08:00AM
Aug-29-23 04:01PM
Aug-25-23 08:00AM
Aug-24-23 04:01PM
Aug-07-23 10:39AM
Aug-05-23 01:03AM
Aug-04-23 09:30AM
07:25AM
06:13AM
06:00AM
Jul-26-23 08:00AM
Jul-21-23 12:10PM
Jul-06-23 10:36AM
08:00AM
Jul-05-23 01:23PM
09:27AM
Jul-03-23 02:32PM
02:08PM
02:01PM
02:00PM
Jun-15-23 08:00AM
Jun-14-23 08:00AM
May-29-23 10:37AM
May-24-23 08:00AM
May-16-23 08:00AM
May-07-23 01:18PM
May-05-23 11:35PM
06:10AM
06:00AM
May-01-23 10:01AM
Apr-28-23 10:00AM
Apr-17-23 08:00AM
06:30AM
04:01AM
Apr-12-23 08:00AM
Apr-03-23 10:39AM
Mar-06-23 09:48AM
Mar-03-23 02:04AM
Mar-02-23 07:25AM
06:01AM
06:00AM
Jan-31-23 08:00AM
Jan-25-23 04:06PM
Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Autor Deborah M.DirectorMay 17 '24Sale6.7323,447157,72893,402May 20 04:10 PM
Autor Deborah M.DirectorMay 16 '24Sale6.7614,55398,378116,849May 20 04:10 PM
BOYER ANDREW SExecutive Vice PresidentAug 11 '23Sale4.1329,302120,921244,739Aug 15 04:30 PM